NCT04175067View on ClinicalTrials.gov

Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

October 31, 2019

Study Completion Date

November 15, 2019

Conditions
Endometrium CancerOxidative Stress
Interventions
DIAGNOSTIC_TEST

Disulphide(μmol/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

DIAGNOSTIC_TEST

Total Oxidant Capacity(μmolH2O2Equiv/L)

Aforementioned oxidative stress markers will be measured via Cobas c501(Roche Diagnostics, Indianapolis, IN, USA) used with sphectrophotometry

Trial Locations (1)

48000

Mugla Sıtkı Kocman University Faculty of Medicine, Muğla

All Listed Sponsors
lead

Muğla Sıtkı Koçman University

OTHER

NCT04175067 - Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer | Biotech Hunter | Biotech Hunter